Weight-loss-program provider Medifast (MED -7.1%) slides after missing on its Q1 EPS result but...


Weight-loss-program provider Medifast (MED -7.1%) slides after missing on its Q1 EPS result but beating on revenue. Net earnings fell 37% Y/Y as costs related to the company's expansion of its weight control centers have put pressure on bottom line margins. Gross margins also narrowed to 75.1% from 76.3%, primarily due to rising commodity and shipping costs.

From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs